Uncategorized
Speaker debunks value of ‘one eye’ trial of medication
WAIKOLOA, Hawaii — The long-held belief that the “one eye” trial of medication is an efficient solution for assessing treatment efficacy for lowering IOP is not true, and the practice should be abandoned, according to a speaker here. “The one eye trial does not work in any way shape or form that is efficient enough for us,” Robert D. Fechtner, MD, told colleagues at Hawaiian Eye. “The one eye trial has been taught throughout my career and has been a standard and advocated. The theory behind the one eye trial (Read more...)